Kinetix Pharmaceuticals Inc.

Pharmaceutical and medical device companies are increasingly turning to corporate venture capital as a self-funding, maybe even profitable, way to manage rapid change and gather business intelligence.

Orphan receptors meet their matches Cambridge Drug Discovery Ltd. is not alone in seeking to accelerate the drug discovery process. Nor is there anything novel about the areas it's chosen to focus

If large molecule therapeutics have largely been the province of biotech companies, Big Pharma has owned the small molecule side of drug discovery. But a number of companies formed in the last couple

Small companies are staking out niches where they think they can do a better job of turning hits into leads than Big Pharma. by Mary Stuart More than once, the nightly news has reported that a new dis